Data / Form D filings / Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc.: Form D filings
Asher Biotherapeutics, Inc., a biotechnology company in South San Francisco, CA, filed 3 Form D notices with the SEC between 2019 and 2024. The latest, on April 16, 2024, reports $55 million sold of a $55 million offering to 16 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 650 GATEWAY BLVD., SUITE 100, South San Francisco, CA, 94080
- Phone
- (650) 628-8110
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1787260
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2024 | New notice | $54,999,990 | $54,999,990 | 16 | Apr 3, 2024 | sec.gov | |
| Sep 7, 2021 | New notice | $107,999,975 | $107,999,975 | 22 | Aug 20, 2021 | sec.gov | |
| Sep 5, 2019 | New notice | $3,000,000 | $490,000 | $2,510,000 | 8 | Aug 19, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Craig Gibbs | Executive Officer, Director | |
| Ivana Djuretic | Executive Officer, Director | |
| Jeffrey Tong | Director | |
| Reid Huber | Director | |
| Kyle Elrod | Executive Officer | |
| Bob Deresiewicz | Director | |
| Elaine Sun | Director | |
| Andy Yeung | Executive Officer | |
| Don O'Sullivan | Executive Officer | |
| Ian Clark | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 15, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Asher Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.